Koshinski Asset Management, Inc. Royalty Pharma PLC Transaction History

Koshinski Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$27.46 - $31.33 $106,517 - $121,529	-3,879 Reduced 26.66%	10,671 $324,000
Q4 2023 Jan 29, 2024	BUY	$26.21 - $29.22 $83,347 - $92,919	3,180 Added 27.97%	14,550 $408,000
Q3 2023 Oct 18, 2023	SELL	$26.26 - $31.38 $40,177 - $48,011	-1,530 Reduced 11.86%	11,370 $308,000
Q2 2023 Jul 28, 2023	SELL	$29.6 - $36.56 $32,560 - $40,216	-1,100 Reduced 7.86%	12,900 $396,000
Q4 2022 Jan 24, 2023	BUY	$39.17 - $44.04 $548,380 - $616,560	14,000 New	14,000 $0

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.